2016，It is the starting year of the country's comprehensive advancement & ldquo; 13th Five -Year Plan & rdquo;，The year of reform of the national new medical reform entered the Three Medical linkage stages，It is the key year for my country's pharmaceutical circulation enterprises to enter the new stage of transformation and upgrading。To promote the reform of the national pharmaceutical and health system，Guarantee & ldquo; Healthy China & RDQUO; Strategic Implementation，Structural reform around the supply side，Enterprise strives to innovate business model、Expand the business format，Cross -border integration Internet technology，Integrate and optimize the supply chain，Exploring the area union、Realize the platform for win -win。In the first half of 2016，The overall operation of the drug circulation industry shows a stable development trend，Stable sales of total sales，Structural adjustment steadily advance，Service capabilities further increase。

 

  1. The basic situation of the operation of the drug circulation industry

 

  (1) The overall scale

 

  According to statistics，In the first half of 2016, the total sales volume of seven major pharmaceutical products nationwide (total sales is tax included) 927.3 billion yuan 1，Deduction of unparalleled factors increased by 12.0%compared to the same period last year，increased 0.4 percentage point。Where，The total sales of the retail market for the drug are 185.5 billion yuan，increased by 10.1%over the same period last year，increased by 1.4 percentage point。

 

  (2) benefits

 

  According to statistics，In the first half of 2016, the main business income of the drug circulation direct reporting enterprise (nearly 1,200) was 651.5 billion yuan，Deduction of unparalleled factors increased by 12.5%year -on -year，increased 0.3 percentage points; achieved total profit of 11.1 billion yuan，Desment of unparalleled factors increased by 11.5%year -on -year，Basically the same year; the average profit margin is 1.7%，increased by 0.1 percentage points compared with the same period last year; the average gross profit margin was 6.8%，increased by 0.4 percentage points compared with the same period last year; the average cost rate was 5.5%，Compared with the same period last year, it increased by 0.5 percentage points。

 

  (3) Industry capital operation

 

  According to statistics，The total business revenue of 20 listed companies in the drug circulation industry in the first half of 2016 was 315.3 billion yuan，increased by 16.0%year -on -year; net profit was 9.97 billion yuan，year -on -year increased by 27.0%; the average gross profit margin was 15.2%，Slightly decreased year -on -year; the average net interest rate is 2.9%，Basically the same year -on -year; the average expense rate is 6.6%，Slightly decreased year -on -year。

 

 

 

  (3) Drug retail companies actively explore new business models to continuously provide value -added services

 

  In the first half of 2016, the size of the pharmaceutical retail market overall showed a growth trend but slowed down。Regulatory stricter，Marketization elimination acceleration，The large -scale chain company represented by listed companies is developing rapidly，Industry concentration further increases。Drug retail companies actively explore new service models，Through mergers and reorganization、Courtyard cooperation、Pharmacy Alliance、E -commerce、Chinese Medicine Museum、DTP professional pharmacies and other forms to carry out innovative business，Provide value -added services，Drug retail model begins to develop major changes。With the advancement of the reform of public hospitals，Control fee in medical insurance、Drug ratio control、Reasonable medication、Prescription outflow and other policies such as prescription outflow，The retail market will get huge sales opportunities，Retail pharmacy will become the most important sales channel in the pharmaceutical industry。

 

  (4) The change of modern pharmaceutical logistics model prompting the industry

 

  The core of the innovation breakthrough in the drug circulation industry in my country is to implement the change of modern logistics model。Using modern logistics equipment and advanced integration management system，Implementing drug logistics information、Intelligent management，and integrated through the supply chain、For the pharmaceutical industry enterprise，For the pharmaceutical industry enterprise、Provide optimization inventory for medical institutions、stake online sports bettingstake betting appSpecification Management、Automatic replenishment a series of value -added services。According to incomplete statistics，Large -scale pharmaceutical circulation enterprises have built drug logistics information management platforms for more than 1,000 medical institutions，Implementation of medicine、Consumption、Medical Institution and other medical institutions for daily necessities、Delivery、Preparation、Intelligentization of the department uses the whole process，Help the hospital to break through the bottleneck of information management，Not only does it consolidate the business development foundation of deepening the drug circulation industry in the core pharmaceutical distribution terminal channel，It also drives the industry from traditional pharmaceutical wholesalers to the role of medical service providers that solve service solutions for customers。Under the trend of medicine separation，This transformation helps promote the hospital to improve the level of informationization，Promote the hospital gradually peeling off the non -core business，Make the hospital's focus on the diagnosis and treatment ability，Re -creation of new core service capabilities in medical institutions in the context of new medical reform，At the same time, the drug circulation industry has the most potential value for the country to promote the new medical reform。

 

  Internet technology is a catalyst in this change，Accelerate the pharmaceutical logistics mode to flatterate、Platform -based development，Mutual penetration of upstream and downstream，Multi -warehouse collaborative delivery，Unified scheduling of warehousing resources and transportation resources，Implementation process reconstruction; development to low -cost new modern green logistics development，Optimized information flow、Logistics，Improve operational efficiency，Reduce the cost of circulation; enhance corporate competitiveness，Improve industry concentration。In this process，Modern Pharmaceutical Logistics has gained development opportunities，Expansion of the depth and breadth of value -added services，Promote the transformation of the drug circulation industry to smart modern pharmaceutical service providers，But there are also large operating pressure and difficulties。

 

  (5) Differential development of pharmaceutical e -commerce models

 

  Current，Domestic pharmaceutical e -commerce models are endless，The whole industrial chain process of deep medicine，Among them, B2C is the most，B2B develops slower，O2O is still in exploration。Facing the huge market of pharmaceutical e -commerce，Traditional pharmaceutical circulation companies and Internet companies outside the industry have shown great enthusiasm。At the same time，Based on the traditional pharmaceutical purchase and sale，Big health services are widely used in the construction of e -commerce platforms，For example, Shanghai Medicine and JD.com & ldquo; Cloud Health & RDQUO; Platform、Guangzhou Pharmaceuticals together with Ali Health、Kyushu Tong and & ldquo; Dr. Chunyu & rdquo; cooperation、China Resources Jianyi.com layout O2O、State Medicine Promotional Medical and Health Industry Platform Construction and Tmall、Baidu、Tencent、Various pharmaceutical e -commerce models such as micro -malls continued to emerge，Transition from B2B mode to B2B2C mode，Transition from traditional commercial trade to modernization of modernization，Differential e -commerce、Diversity、Innovative development provides model innovation、Typical cases of concept innovation。But the national policy of the emerging field of pharmaceutical e -commerce is still in cautious adjustment，August 1, 2016 officially stopped the pilot work of the third -party platform online pharmaceutical retail。

 

  Future，With the "Qualification Certificate of Internet Drug Transaction Service" B、C certificate of approval right to the Provincial Drug Administration，Enterprises entering the field of pharmaceutical e -commerce will be more convenient，Provide policies for the rapid development of e -commerce business，But at the same time, it is also selected for enterprise profit points、Market subject positioning、More requirements for capital demand，Differential development of pharmaceutical e -commerce models seems to be more important。According to statistics from the State Food and Drug Administration，As of June 30, 2016, companies with Internet transaction qualifications are 595，Number of enterprises increased by 40.0%year -on -year，Among them, B2B is 123、B2C is 449。

 

  Three, the development trend forecast of the drug circulation industry

 

  (1) The new national policy environment will have a greater impact on the development of the industry

 

  The country has been in & ldquo; 135 & rdquo; strategic plan，& ldquo; Two sessions & rdquo; Government work report and the national key work opinion of the national reform of the economic system，Around & ldquo; Three Medical Links & RDQUO; Promoting the medical reform into the deep water area to put forward clear ideas，The value positioning of how to reconstruct the drug circulation industry in the process of promoting the new medical reform in the country、Consolidate the long -term health of the drug circulation industry

 

  Stake Sports Bettingstake online sports bettingDevelopment has far -reaching significance。In recent months，The "Guiding Opinions on Promoting the Healthy Development of the Pharmaceutical Industry" and "Regarding the Reform of the Health System Reform 2016 Key Work Task" issued by relevant national departments，Establish a modern drug circulation system for the industry、Building a new order of drug circulation indicates the direction of development。

 

  & ldquo; in 2016 & ldquo; business reform increase & rdquo;、& ldquo; two -vote & rdquo;、Multiple policies of compliance rectification and imitation drug consistency evaluation，The pharmaceutical industry will usher in a large shuffle and shock，The overall policy tends to be large enterprises，Guide and encourage enterprises to upgrade industrial、Runction of scale，Improve industry concentration，Improve the international competitiveness of the enterprise。Optimized circulation links，Not only improves the efficiency of drug circulation，It also reduces the overall logistics cost，Putting higher demand for the logistics services of drug circulation enterprises。Control fee in medical insurance、Under the mainstream trend of payment method reform，The pressure of the drug circulation industry increases，Limited development of small and medium -sized commercial companies，The financial ability of the enterprise is facing a test，The operating cost will also be further increased。but，The new policy environment is conducive to the strengthening of large -scale operating enterprises、Do it、Make fine，is a change in the process reengineering of the business model & rdquo;，It is conducive to adjustment of corporate organizational structure and architecture，Bring a change in the pattern of pharmaceutical companies。From it，Large enterprises will get a greater advantage，Standing in the industry。At the same time，With the further liberalization of the future policy，Large pharmaceutical business companies will be able to try PBM (drug welfare management)、GPO (Small and Small Hospital Concentrated Procurement Organization) and other new business experience。Facing policy and market environment，The company should follow the trend，Grasp the opportunity、Pioneering Innovation、Seeking development。

 

 (2) Large -scale drug circulation enterprises have gradually become the main force to promote the unified market of drug circulation

 

  Statistics data show that 2015 my country's pharmaceutical circulation market commercial wholesale and retail pharmacy terminal market is close to 10%of the two -digit bottom line growth level，The development of large -scale pharmaceutical wholesale enterprises and retail pharmacy terminal enterprises in 2015 is even more prominent，Its growth rate is 15.6%and 13.1%, respectively，The growth rate of the overall market and the retail market is nearly 5 percentage points higher; in addition,，The market share of the top 100 large -scale pharmaceutical wholesale enterprises and retail pharmacy terminal enterprises increased from 65.9%and 28.1%in 2014 to 68.9%and 28.8%in 2015，Maintain a continuous growth trend。

 

  From the overall classification statistics of the above industry market, it can be seen，Large pharmaceutical circulation enterprises have increased the concentration of my country's pharmaceutical circulation market to nearly 70%，and 15 companies with annual main business income of 10 billion yuan have gradually approached 50%of my country's pharmaceutical circulation market，Da & ldquo; Half of the mountains & rdquo;，further strengthened the trend of intensiveization levels in Asia and other Asian -leading markets such as Japan and South Korea。In -depth analysis of the top 20 companies in my country's drug circulation industry in 2015，You can see these 20 pharmaceutical circulation companies as the leader who represents the leading development of the drug circulation market in my country，Sustainable development at the speed of surpassing the average growth level of the market，It shows that these large pharmaceutical circulation companies can effectively resolve the various unfavorable factors brought by the current macroeconomic environment and policy environment in my country，Especially after being able to calmly cope with the new medical reform in my country, after entering the deep water area,，Traditional business model for the drug circulation industry、Traditional value positioning and the subversion and challenge of the development pattern of the industrial chain。Large pharmaceutical circulation enterprises have been able to achieve faster in recent years、higher、stronger development，will definitely continue to improve the industry、Market concentration，Promoting the formation of a unified nationwide drug circulation market，Increases the efficiency of drug circulation in my country、Reducing the cost of circulating costs to assume due historical mission and responsibility。

 

  (3) Innovative business model、Enhancement of service value becomes the road to sustainable development of the industry

 

  Current，The pharmaceutical circulation industry has entered the micro -profit era。Government policy frequently，Enterprises have also explored innovative business models，Integrate resources from the circulation links from production enterprises to terminal customers，Continuously expand business space and service scope，Extension My stake betting appMy stake betting appof the supply chain service，will be connected with the information of the upstream industrial enterprises、Inventory management、Zero inventory management of operation management and downstream customer pharmacy cooperation、Operation management、Information value -added services and other income into the scope of the service provided by the enterprise。In addition，Drug circulation process upgrades with Internet technology to become the most competitive pharmaceutical business model in the future，such as smart logistics、Smart pharmacy、dtp、O2O、Cloud Service Platform, etc.。The pharmaceutical platform and medical service platform established by Baiyang Pharmaceutical Group combined，Support for through big data and cloud platform HIS system，Formed a systematic & ldquo; prescription medicine-DTP pharmacy-prescription courtyard externalization overall solution & rdquo;，Create & ldquo; side branch cycle & rdquo; path，Solving the marketing of prescription drugs & ldquo; electronic prescription & rdquo; Question，provided the industry with high -efficiency and innovative ecological model。Shanghai No. 1 Pharmaceutical Co., Ltd. signed a cooperation agreement with Xuhui Yun Hospital，Become Shanghai's first & ldquo; Internet+medical cloud service & rdquo;，formed with & ldquo; Dr. Yun & rdquo;、& ldquo; cloud medical & rdquo;、& ldquo; Cloud Pharmacist & rdquo; and other supporting service modes，Getting on the line online、Seamless docking advantages of offline formula，In the pilot pharmacy，The sales of prescription drugs have increased significantly。In short，Only insist on innovation，Find the way of breaking the situation，Enhance service value，can you master the core competitiveness，Realize industrial upgrading，Sustainable development in the fierce competition。

 

  (4) & ldquo; Internet+drug circulation & rdquo; model will effectively promote the development of pharmaceutical supply chain collaborative development

 

  Relying on drug circulation in the medical supply chain, business flow、Logistics、Data flow and capital flow & ldquo; the status of the four streams & rdquo;，Copy enterprise as the core，Extension upstream and downstream，Short the circulation chain，Reduce the weekly transfer time，Reduce the average inventory，will be integrated upstream and downstream，To integrate and optimize the pharmaceutical supply chain，Improve operating efficiency。Through & ldquo; Internet+drug circulation & rdquo; mode，Establish a distributed multi -synergistic modern drug circulation system for upstream and downstream of the supply chain，It can effectively allocate government and corporate resources，Reduce overall social circulation cost，Promote the development of supply chain collaborative development，Become an effective support for the development goals of the 13th Five -Year Plan & rdquo;。Supply Chain Coordinated Development，It will also promote the docking of pharmacies and pharmacies in the hospital in the hospital，Use & ldquo; Internet+& rdquo; thinking and means，Create a new model of drug circulation for multi -party collaboration。Use & ldquo; Internet+drug circulation mode & rdquo;，It is conducive to the establishment of the standard data standard system，Realize the public structure of cross -departmental data resource sharing; at the same time, it can give birth to the smart supply chain、Smart Logistics、Public service platforms and other forms quickly emerged，Promoting the innovation process of the industry，Reflection of promoting business management，Improve the level of industry development、Collection level、scale level。

 

  With the continuous improvement of the policy、The increasing progress of technology、Standards gradually establish，The pharmaceutical supply chain will be increasingly integrated，Traditional industry cooperation methods will also continue to innovate and integrate，Forms the Internet as the development and sharing、Win -win cooperation、Efficient and convenient、Green and safe smart medicine supply chain，Makes the supply chain in more efficient in all aspects of the supply chain、Cross -border cooperation is closer。thus breaking through traditional inertia thinking，Beyond the old business philosophy，Create a win -win ecological supply chain system。

 

  (5) Retail market opportunities and challenges coexist，Diversified operation、Professional service becomes an inevitable development trend

 

  Over the years，Under the institutional mechanism of & ldquo; for medicine & rdquo;，Public hospitals are always dominant in the prescription drug market，Hospital prescription is difficult to flow out。Since 2015，The State Council issued a series of policies，Including the proportion of controlling drugs、Monitoring Auxiliary medication、Multi -point practice incentive for doctors、Do not limit the hospital's prescription outflow, etc.。The implementation of the zero difference rate through these policies and drugs，It will turn the pharmacy from the profit department of the hospital into a cost department，Promote the outflow of the hospital's prescription，This will bring new opportunities My stake betting appstake sports betting appto retail pharmacies or pharmaceutical e -commerce，At the same time, drive the new round of rapid growth of the entire domestic pharmaceutical retail market。

 

  2016 is both & ldquo; 135 & rdquo;，It is also the year of tackling the country to promote supply -side structural reforms。With the national comprehensive deepening of the reform of the medical and health system，Promoting simplified administration and release、Pipe tube combined to change government functions，Industry policy is frequently introduced，The development of the pharmaceutical retail industry brings opportunities and brings greater challenges。After cancellation of the examination and approval of fixed -point medical insurance，Loose access brings stricter supervision; public hospital reform、Drug ratio and zero -difference rate policy，It will make more prescriptions flow to social pharmacies。Drug retail enterprises can only improve the level of professional management and the professional ability of pharmacy service personnel，After truly professional service capabilities，Only to lay the foundation for undertaking the medical institution outpatient pharmacy service。At the same time，Online Pharmacy、Mobile Internet、Electronic prescription cloud platform and other Internet B2C sales of the rapid development，further accelerating industry innovation and transformation; social capital intervention，Retail pharmacy holding a group heating，Large pharmacy retail chain companies expand rapidly，It will inevitably promote the concentration of the industry to further increase。Pharmaceutical retail enterprises under the condition that opportunities and challenges coexist，Improve your service ability、Greed up the scope of corporate service，Realization of diversified operations、Professional services will become an inevitable trend。From the traditional pharmaceutical circulation terminal to providing pharmaceutical services、Medical Information、Nutrition Consultation、Slow Disease Management、Health Management、The electronic medical records & ldquo; big health service terminal & rdquo; transformation，and form an offline entity、Online B2C、Online and offline O2O multi -channel sales pattern，Find a way for the survival of the industry，Contributions to the deepening of national medical reform and the health guarantee for the health of the people。

 

  (6) The capital operation of the drug circulation industry continues to active，M & A growth has become the main growth mode of some companies

 

  With the advancement of the policy and the intensification of competition，More and more pharmaceutical circulation companies have grown through capital operations，If listed companies generally raise funds through non -public offering and other reinforcements，Non -listed companies often use private equity investment funds to develop themselves，At the same time, choose to listen to the new third board or Chongguan IPO。M & A is also an important means for the growth of pharmaceutical circulation enterprises，In the past few years，Chinese Medicine Holdings、China Resources Pharmaceuticals and other circulation enterprises have quickly developed into the national drug circulation industry through mergers and acquisitions。In recent years，Regional circulation enterprises (such as Jiashitang and Ruikang Pharmaceutical, etc.) and retail chain companies (such as one heart hall、People and Yifeng Pharmacy, etc.) also increased the pace of mergers and acquisitions。Driven by capital operations such as mergers and acquisitions and reorganizations，The concentration of the domestic drug circulation industry will continue to increase for a long time。